Moreno, C., Berg, T., Tanwandee, T., Thongsawat, S., Vlierberghe, H. V., Zeuzem, S., . . . Smedt, G. D. (2018). Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study.
Chicago Style CitationMoreno, Christophe, et al. Antiviral Activity of TMC435 Monotherapy in Patients Infected With HCV Genotypes 2-6: TMC435-C202, a Phase IIa, Open-label Study. 2018.
MLA CitationMoreno, Christophe, et al. Antiviral Activity of TMC435 Monotherapy in Patients Infected With HCV Genotypes 2-6: TMC435-C202, a Phase IIa, Open-label Study. 2018.
Warning: These citations may not always be 100% accurate.